Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Jun. 30, 2019
Current assets    
Cash and cash equivalents $ 2,392,402 $ 3,718,758
Prepaid expenses and deposits 355,580 280,248
Interest, taxes and other receivables 9,401 26,187
Deferred loan costs 93,701  
Current assets 2,851,084 4,025,193
Intangible assets - net 2,109 12,062
Deferred financing costs 84,944  
Total assets 2,938,137 4,037,255
Current liabilities    
Accounts payable and accrued liabilities 2,011,058 1,744,517
Related party payables 663,865 325,208
Total liabilities 2,674,923 2,069,725
Stockholders’ equity    
Zero special voting shares at June 30, 2020 (June 30, 2019 – 1) 0 0
Common stock Authorized 95,000,000 shares at June 30, 2020 and June 30, 2019, $0.001 par value 11,457,928 issued at June 30, 2020 (June 30, 2019 – 3,839,358) 11,458 3,839
Additional paid-in capital 56,624,048 50,954,741
Warrants 8,524,336 6,588,283
Accumulated deficit (69,721,233) (60,578,345)
Accumulated other comprehensive income 21,178 21,178
Total stockholders’ equity 263,214 1,967,530
Total liabilities and stockholders’ equity 2,938,137 4,037,255
Preferred Stock Series A    
Stockholders’ equity    
Preferred stock 278,530 278,530
Preferred Stock Series B    
Stockholders’ equity    
Preferred stock 4,524,897 4,699,304
Total stockholders’ equity $ 4,524,897 $ 4,699,304